News Combination between Novozymes and Chr. Hansen approved by the Novozymes shareholders Staff March 30, 2023 Please read the announcement in PDF Attachment 2023_50_Combination_between_Novozymes_and_Chr._Hansen_approved_by_the_Novozymes_shareholders Continue Reading Previous GSK and SCYNEXIS Announce an Exclusive Agreement to Commercialise and Further Develop Brexafemme (ibrexafungerp), a Novel, First-in-Class Medicine to Treat Fungal InfectionNext Combination between Novozymes and Chr. Hansen approved by Novozymes’ shareholders More Stories Hospitals News Nursing Hankyung.com introduces: MecKare, Leading the AI-powered Innovation in Health Monitoring Solution Staff November 23, 2024 Brain Clinical Trial Healthcare News Pharmaceutical Pregnancy Attruby™ (acoramidis), a Near Complete TTR Stabilizer (≥90%), approved by FDA to Reduce Cardiovascular Death and Cardiovascular-related Hospitalization in ATTR-CM Patients Staff November 23, 2024 Healthcare Hospitals News Nursing Patient Care Redefining the Standard of Care: Introducing the Aulisa® Monitor Camera for Advanced Patient Monitoring Staff November 23, 2024